A mother of two beautiful children, Lucie Clark was diagnosed with multiple sclerosis while she was slowing losing her eyesight and ability to walk.
Indian Stem Cell Technology Receives Patent to Treat Incurable Diseases
An Indian scientist, Dr. Geeta Shroff of Nutech Mediworld has created a new ground breaking stem cell technology to treat incurable diseases such as diabetes, Parkinson’s disease, spinal cord injury, cerebral palsy, stroke and many others using embryonic stem cells. Recently, this technology has been granted the 66th patent in Malaysia for treating the above mentioned medical conditions.
The technology utilizes stem cells from human embryo that are isolated, cultured, processed and stored in a ready-to-use form for clinical application. Using embryonic stem cells for treatment may cause ethical concerns in the research world but Dr. Shroff created pure human embryonic stem cell lines using a single, spare, pre-implanted fertilized egg from a regular IVF cycle. The team received the fertilized egg in compliance with the regulatory guidelines and complete consent from the patient in the year 2000. The same original embryonic stem cell line is used till date without the need for more fertilized eggs.
Dr. Shroff’s technology is different from other stem cell therapies available across the world in 3 major ways:
- It can be used by anyone as the stem cells from embryonic origin do not require a match or HLA Typing. It is universal and can be used, much like insulin.
- This is a clinic based technology. The stem cells are readily available for transplants with a shelf life of 6 months. Thus, it can be easily transported and used without any time delay.
- The stem cells can be administered through a simple and safe delivery mechanism in the form of injections.